Barinthus Biotherapeutics PLC (BRNS)
1.83
-0.08
(-4.19%)
USD |
NASDAQ |
Jun 14, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
Barinthus Biotherapeutics Total Assets (Quarterly): 199.48M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 199.48M |
| December 31, 2023 | 214.51M |
| September 30, 2023 | 229.97M |
| June 30, 2023 | 246.13M |
| March 31, 2023 | 261.82M |
| December 31, 2022 | 270.20M |
| September 30, 2022 | 275.48M |
| Date | Value |
|---|---|
| June 30, 2022 | 285.06M |
| March 31, 2022 | 286.12M |
| December 31, 2021 | 280.72M |
| September 30, 2021 | 256.57M |
| June 30, 2021 | 259.84M |
| March 31, 2021 | 166.49M |
| December 31, 2020 | 50.67M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
50.67M
Minimum
Dec 2020
286.12M
Maximum
Mar 2022
234.50M
Average
258.20M
Median
Total Assets (Quarterly) Benchmarks
| Achilles Therapeutics PLC | 145.74M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Virax Biolabs Group Ltd | 7.025M |
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.47M |
| Shareholders Equity (Quarterly) | 171.83M |